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Purpose: Chronic ocular pain is poorly understood and difficult to manage. We
developed a murine model of corneal surface injury (CSI)–induced chronic ocular
neuropathic pain. The study focuses on changes in corneal nerve morphology and
associated short- and long-term pain-like behavior after CSI.
Methods: CSI was induced in mice by local application of an alkali solution (0.75 N
NaOH). Corneal nerve architecture, morphology, density, and length were studied.
Eye-wiping was evaluated before and after CSI in response to hypertonic saline (2 M
NaCl). Naltrexone (NTX) or Naloxone-methiodide (NLX-me), opioid receptor antago-
nists, were given subcutaneously (s.c., 3 mg/kg) or topically (eye drop, 100 lM), and
then an eye-wiping test was performed.
Results: CSI caused partial corneal deinnervation followed by gradual reinnervation.
Regenerated nerves displayed increased tortuosity, beading, and branching. CSI
enhanced hypertonic saline-induced eye-wiping behavior compared to baseline or
sham-injury (P , 0.01). This hypersensitivity peaked at 10 days and subsided 14 days
after CSI. Administration of NTX, or NLX-me, a selective peripheral opioid antagonist,
reinstated eye-wiping behavior in the injury group, but not in the sham groups (P ,
0.05).
Conclusions: This study introduces a model of chronic ocular pain and corneal
neuropathy following CSI. CSI induces central and peripheral opioid receptor-
dependent latent sensitization (LS) that is unmasked by systemic or topical
administration of opioid antagonists.
Translational Relevance: This model of chronic ocular pain establishes LS as a new
inhibitory mechanism in the oculotrigeminal system and may be used for potential
diagnostic and therapeutic interventions for ocular neuropathy.
Introduction
Ocular neuropathic pain is a poorly treatable,
debilitating condition that negatively impacts the
quality of life of millions in the United States.1,2
Numerous, diverse etiologies exist for ocular neuro-
pathic pain that are broadly classified by nature of
insult (mechanical, thermal, chemical, or infectious),
and usually involve pathology of the cornea, a densely
innervated tissue.3,4 Emerging evidence indicates that
corneal sensory neuropathy is a common underlying
mechanism of ocular neuropathic pain.5–7 However,
despite an increasing recognition of the importance
and prevalence of ocular neuropathic pain, diagnosis
and management remain challenging due to a paucity
of clinical correlates on ophthalmologic exam, as well
as the need to better understand underlying neurobi-
ology and pathophysiology.
A major limitation to existing ocular pain models
(e.g., humidity chambers, topical pollutant or BAC
1 TVST j 2019 j Vol. 8 j No. 2 j Article 6
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.Downloaded from tvst.arvojournals.org on 08/15/2019
administration, corneal cauterization, oral finasteride,
or extraorbital lacrimal gland excision) is that they
assess predominantly acute pain behaviors that are
short-lived.8–13 Given that ocular neuropathic pain
follows a chronic and relapsing–remitting course,14
we developed an animal model that better recapitu-
lates the chronicity of ocular neuropathic pain.
Nociceptive signals in chronic neuropathy are
mediated by inflammation and/or tissue damage that
enhances the sensitivity of peripheral neurons (pe-
ripheral sensitization) and central neurons.15 Nerve
injury causes chronic neuronal sensitization via long-
term potentiation of nociceptive neurons. Recent
studies have established that chronic nerve sensitiza-
tion is silenced by endogenous opioid receptors in a
process known as latent pain sensitization (LS).
Opioid receptor antagonism disrupts LS and rein-
states pain precipitating cellular, somatic, and aver-
sive signs of physical withdrawal in animals.
Therefore, LS is an important pain inhibitory
mechanism, but also represents a state of increased
susceptibility to pain reinstatement.16,17 Whether this
adaptive response contributes to chronic ocular pain
after injury to the corneal surface has not been
established to our knowledge.
We established a model of sustained ocular
hypersensitivity associated with corneal neuropathic
changes. It combines local application of an alkali
solution to induce a controlled corneal surface injury
(CSI) with topical application of a hypertonic saline
solution to elicit eye-wiping behavior. We also
defined the anatomic pathology in corneal nerve
fiber layers in terms of nerve density, length, and
architecture throughout 42 days after injury. Finally,
the opioid receptor inverse agonists, naltrexone
(NTX) and naloxone-methiodide (NLX-me), are
used to test whether LS contributes to chronic
ocular pain.
Methods
Animals
Male C57BL/6 mice were purchased from the
Jackson Laboratory (Bar Harbor, ME) and studied
beginning at 8 weeks of age. All animal-based
procedures were performed in accordance with the
Association of Research in Vision and Ophthalmology
(ARVO) Statement for the Use of Animals in
Ophthalmic and Vision Research and the National
Institute of Health (NIH; Bethesda, MD) Guide for the
Care and use of Laboratory Animals. The experimental
protocol was approved by the institutional animal care
committee for animal research of the University of
Kentucky.
Corneal Surface Injury (CSI)
All mice were anesthetized with an intraperitoneal
(i.p.) injection of ketamine (125 mg/kg)/ xylazine (7
mg/kg). Deep anesthesia was confirmed by lack of
response to toe pinch. Alkali-immersed filter discs
were used to induce corneal injury in mice.18 What-
man filter paper was used to prepare discs with 4 mm
diameter. Filter paper discs were soaked in sodium
hydroxide solution (NaOH; pH 13.0 6 0.05; 0.25 N,
0.75 N, 1 N) for 10 seconds. The discs then were
blotted with a paper towel to remove excess NaOH
solution. The wet filter paper discs were placed on the
center of the corneal surface for 10 seconds. The
contact area between the disc and cornea was limited
to a central circle of approximately 2 mm diameter.
After its removal, the entire ocular surface was
irrigated immediately with 10 mL balanced salt
solution (BSS), using a 10 mL syringe with an 18-
gauge (G) blunt needle. The corneal surface then was
massaged gently with the smooth side of forceps to
remove damaged tissue. Afterwards, a second round
of irrigation to the entire ocular surface was
performed with an additional 10 mL BSS. After
debridement, neomycin and polymyxin B sulfate
(Bausch & Lomb, Inc., Tampa, FL) were applied to
the entire ocular surface of both eyes to prevent
dryness and infection. For the sham group, neomycin
and polymyxin B sulfates were applied after anesthe-
sia was induced. After these procedures, mice were
placed on a heating pad until fully awake and then
returned to their home cage.
Behavioral Study
Testing Apparatus
Two frameless square mirrors were linked together
at a 608 angle by a metal hinge. A clear open-top
acrylic cylinder with a 13.5 cm diameter and 17 cm
height was placed between the mirrors. The mouse
was placed inside the clear cylinder and its reflection
was shown on the mirrors, which allowed visualiza-
tion of the face regardless of the mouse position. The
bottom of the cylinder was covered with a circular
filter paper, which was replaced before each subse-
quent testing. A video camera was placed in front of
the cylinder and behavioral responses were recorded
(Supplementary Fig. S1).
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Eye-wiping Test
One week before measuring the baseline, mice were
habituated to the testing environment for 10 minutes
on three separate days. On testing days, mice were
first acclimated to the testing apparatus for 10
minutes. Then, mice were grasped gently and one
drop of sodium chloride solution (NaCl; pH 7.4 6
0.05; 1, 2, or 3 M) was applied to the center of the
corneal surface of the right eye, using a 25 G needle
attached to a BSS bottle; care was taken to avoid
touching the ocular surface. Ten seconds after
application of NaCl, mice were returned to the testing
apparatus and the number of eye wipes performed
with the ipsilateral forepaw was counted for 30
seconds duration. Hind paw wipes/scratches were
very rare and not included. Next, the entire ocular
surface was irrigated with 10 mL BSS, and mice were
returned to their home cage.
Drug Administration
NTX hydrochloride (cat. No. 0677; TOCRIS,
Bristol, United Kingdom) was subcutaneously (s.c.)
administered (3 mg/kg in BSS) in a volume of 10 mL/
kg and eye-wipe testing was performed with 2 M
NaCl at 30 minutes after administration of NTX.
NTX dosing and timing were performed as previously
reported by Corder et al.17 NLX-me (cat. No. N129;
Sigma-Aldrich Corp., St. Louis, MO) was topically
instilled (100 lM in BSS) and eye-wiping test was
performed 50 minutes after instillation of NLX-me
eye drop. Dosing of NLX-me was based on previous
published work on the topical application NTX at 100
lM dose.19 Hypersensitivity after NLX-me was not
observed until 50 minutes after instillation.
Immunofluorescence Staining and Imaging
of the Whole Cornea Flat Mount
Animals (n ¼ 3 for each time point) were
euthanized. Then, the eyes were enucleated and fixed
in freshly prepared 4% paraformaldehyde (PFA) for 15
minutes. The corneas were excised along the limbus
and fixed in 4% PFA for 45 minutes, followed by two
washes in 13PBS for 5 minutes per wash. The corneas
then were placed in ice-cold methanol for 20 minutes,
followed by two washes with 13 PBS for 10 minutes
per wash. To block nonspecific binding, corneas were
incubated with blocking solution (10% normal goat
serum, 3% bovine serum albumin [BSA], 1% Triton-X,
0.05% Tween 20, 0.05% sodium azide) in 1 3 PBS
overnight at 48C. The corneas then were incubated
with rabbit anti-b III-tubulin antibody (18207; 1:200;
Abcam, Cambridge, UK) for 72 hours at 48C, followed
by incubation with goat anti-rabbit Alexa Fluor 488
(1:200; (EMD Millipore, Burlington, MA) for 2 hours
at room temperature. After washing with 1 3 PBS
three times (10 minutes/wash), four radial cuts were
made to the whole cornea to flatly mount it on a slide
with the endothelium side down, and then cover
slipped with ProLong Gold antifade reagent without
40,6-diamidino-2-phenylendole (DAPI).
Three-dimensional (3D) reconstruction of the
corneal nerve networks was performed with confocal
microscopy (1 lm slices). The central 232 mm square
was imaged from the epithelial to the stromal layer
(Nikon Eclipse A1Rþ; Nikon Corp., Tokyo, Japan)
with a 320 and 360 objective lens. The images
obtained from the same layer of the cornea were
merged.
Nerve fiber density and length were assessed in the
central 4 mm2 area in the epithelial, subbasal, and
stromal layers of each cornea. Density was calculated
using ImageJ software as previously described20 and
length was calculated using Angio Tool software.21
This was performed in sham- and alkali-treated
corneas at 2, 10, 21 and 42 days after injury.
pERK Stimulation and Staining
To identify sensitized neurons in the trigeminal
ganglion (TG), 2 M NaCl solution was instilled onto
the mouse right eye in all groups except a naı¨ve group.
Anesthesia and perfusion were completed within 10
minutes post 2M NaCl application.
Mice deeply anesthetized with ketamine (125 mg/
kg)/xylazine (7 mg/kg) were perfused with ice-cold
BSS, and then fixed by ice-cold 4% PFA. Following
perfusion and fixation, the head was decapitated and
the TG tissue was harvested. The TG tissue was
postfixed in 4% PFA for 1 hour. After serial washes in
13 PBS, TG tissue was cryoprotected in 15% sucrose
overnight. Next day, TG was embedded in Tissue-Tek
optimal cutting temperature (OCT) compound and
stored at808C. Frozen TG tissue then was sectioned
into 10 lM thickness at 308C, using the cryostat.
The TG then was sectioned in 10 lm slices from its
dorsal surface and the 15th section located approx-
imately 150 lm deep. This slice, which contains the
greatest number of neuronal cell bodies from corneal
afferents, was used for neuronal activation quantifi-
cation.22 TG sections were treated with blocking
solution (2% normal donkey serum, 1% BSA, 0.1%
Triton-X, 0.05% Tween 20, 0.05% sodium azide in
BSS) for 1 hour at room temperature, followed by
overnight incubation with Alexa Fluor 488-conjugat-
ed mouse anti-NeuN (MAB377X; EMD Millipore)
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and rabbit anti-pERK (4370; Cell Signaling Technol-
ogy, Danvers, MA) antibodies at 48C. Next day,
sections were washed in 13 PBS twice and incubated
in donkey anti-rabbit secondary antibody conjugated
with Alexa Fluor 594 for 2 hours at room tempera-
ture. After serial washes in 1 3 PBS, sections were
cover-slipped with anti-fade ProLong Gold contain-
ing DAPI. Images were captured using the confocal
microscope (Nikon Eclipse A1Rþ; Nikon Corp.) with
a320 objective lens.
Data Analysis
Behavioral Study Data
One-way ANOVA was used to compare the area
under the curve (AUC) of multiple NaOH doses within
the same concentration of NaCl, and then post hoc
Tukey tests were performed. Linear mixed models were
used to compare group means while accounting for
correlation that occurs with repeated measurement
using SAS v9.4. Covariance structure was selected
using information criteria where smaller is better.
Results are presented as the mean 6 standard error of
the mean (SEM); for repeated measures analysis with
significant time-group interactions group means are
presented by time point. P  0.05 was considered a
statistically significant difference among groups.
Nerve Fiber Quantification Data
An analysis was performed at each layer (epithe-
lial, subbasal, and stromal). One-way ANOVA was
used to compare the density of corneal nerve fibers in
injury group at multiple time points and post hoc
Tukey tests then were performed. Student’s t-test
compared the length of corneal nerve fibers in sham
and injury groups. Results are presented as the mean
6 SEM. P  0.05 was considered a statistically
significant difference among groups.
pERK Quantification Data.
Two blinded examiners independently counted the
total number of NeuN-positive neurons as well as of
pERK-positive cells that are colocalized with NeuN
within V1 area in each TG. Then, the number of
pERK-positive neurons was divided by the number of
NeuN-positive neurons, multiplied by 100 to find %
pERK positive neurons.
% pERK positive neurons
¼ number of pERK positive neurons
number of NeuN positive neurons
3 100
Student’s t-test was used to compare the mean
%pERK-positive neurons between the two groups.
Results
CSI Causes Ocular Hyperalgesia
The alkali burn model of CSI was used to study
corneal sensitivity.18 In this model, mice underwent
an alkali burn injury with a NaOH-soaked filter paper
disc and eyes were tested for hypersensitivity with
measurement of eye-wiping behavior following cor-
neal application of a drop of NaCl hypertonic
saline.23 To identify the optimal concentration of
injury and stimulus, we tested multiple concentrations
of NaOH and NaCl solutions: vehicle or NaOH (0.25,
0.75, and 1.0 N) and NaCl (1, 2, and 3M). Preliminary
testing of the highest NaOH concentration (1 N)
caused corneal perforation in four of six mice tested
and, therefore, was excluded.
Eye-wiping behavior was assessed at baseline, and
2, 4, 7, 10, 14, and 21 days after CSI, and the AUC
from the baseline to day 21 was calculated (Fig. 1A).
Interestingly, when 1 M NaCl or 3 M NaCl solution
was used as stimulus, sham and CSI groups (0.25 N
NaOH, 0.75 N NaOH) showed similar eye-wiping
behavior (Fig. 1A). We concluded that 1 M NaCl may
not be noxious enough to generate robust response in
the CSI group. In contrast, 3 M NaCl solution could
be too strong and elicited high wiping behavior in
sham and CSI groups. We found, however, that 2 M
NaCl stimulation resulted in a robust increase in 0.75
N NaOH-treated CSI animals compared to sham
controls (Fig. 1A, overall P , 0.01; sham vs. 0.75 N
NaOH; P , 0.05). Thus, all subsequent experiments
were performed using this combination of injury and
stimulus intensities.
We next evaluated the time course of CSI-induced
ocular hyperalgesia. Overall, the groups changed
differently over time (Fig. 1B, group*time, P , 0.05).
Specifically, the CSI group significantly increased the
number of eye wipes at post-injury day 10 compared to
the baseline level (Fig. 1B, P , 0.01) and the sham
group (Fig. 1B, P , 0.05). At day 21, hyperalgesic
behavior in the CSI group returned to baseline for up
to 42 days after injury, consistent with remission of
ocular hyperalgesia (Fig. 1B). In contrast, no changes
in eye-wiping were noted in the sham group through-
out the 42 days (Fig. 1B, P . 0.05).
CSI-Induced Corneal Neuropathy
To determine the degree and duration of corneal
nerve disturbance after CSI, we evaluated the
architecture of corneal nerves at different time points
4 TVST j 2019 j Vol. 8 j No. 2 j Article 6
Cho et al.
Downloaded from tvst.arvojournals.org on 08/15/2019
by calculating corneal nerve density in epithelial,
subbasal, and stromal layers independently (n ¼ 3
corneas/time point; Figs. 2–4). Representative images
of the entire cornea are shown on Supplementary
Figure S2. Two days after CSI, corneal nerve density
was significantly decreased in all three layers of the
cornea compared to baseline (Figs. 2–4, P , 0.01). In
particular, this effect was most dramatic in the
epithelial layer of the cornea where nerve-like
structures were not observed. On subsequent time-
points, the density of nerves gradually increased in a
time-dependent manner. By 42 days after CSI, the
epithelial and stromal layers were fully reinnervated
compared to baseline; however, density in the
subbasal region remained relatively low compared to
sham (Figs. 2–4, P , 0.01).
Although the central cornea remained relatively
denervated at 42 days after CSI (red circle; Fig. 5B),
the epithelial nerve density returned to baseline (Fig.
2A). Therefore, we sought to evaluate the morphol-
ogy of corneal nerves in each layer separately. The
distribution and arrangement of nerve terminals were
dramatically altered with increased length (Fig. 5C)
and presence of neuroma-like structures (Figs. 5IIIa,
Figure 1. Corneal surface injury causes ocular hyperalgesia. (A) AUC for eye-wiping behavior from baseline through 2, 4, 7, 10, 14 days
to 21 days after CSI in sham and CSI groups (0.25 N NaOH, 0.75 N NaOH) with three different concentrations of NaCl solutions (1, 2, and
3M). One-way ANOVA was used to compare AUC of NaOH doses within the same concentration of NaCl, and then post hoc Tukey tests
were performed (##P, 0.01). (B) Number of eye wipes in sham (n¼ 7) and CSI (0.75 N NaOH; n¼ 5) groups at baseline and 2, 4, 7, 10, 14,
21, and 42 days after CSI after an application of 2 M NaCl. Linear mixed models were used to compare the groups over time (between
sham and CSI: #P , 0.05, within CSI: **P , 0.01). The data are presented as mean6SEM.
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5IVa). Nerves in the peripheral subbasal and stromal
layers showed increased beading (arrow) and tortu-
osity (Figs. 5Ib–IVb, 5Ic–IVc). The 3D reconstruction
images (Figs. 5Id–IVd) revealed that neuroma-like
structures in the epithelial layer of the injured corneas
were originating directly from stromal nerves bypass-
ing the diminished subbasal plexus. In regard to nerve
length, while the epithelial terminals became longer
after injury, the subbasal layer had shorter nerve
fibers and the stromal layer was unchanged (Fig. 5C).
Together, these data indicated that CSI caused a
rearrangement in corneal nerves resulting in structural
abnormalities including neuroma formation in the
epithelial layer, profound loss of nerve density in the
subbasal nerves and increasing beading and tortuosity
of stromal nerve trunks.
Figure 2. Evaluation of corneal nerves in the epithelial layer
following corneal surface injury. (A) Density of mouse corneal
nerve endings in the epithelial layer at baseline, 2, 10, 21 and 42
days after CSI (n ¼ 3 for each time point). One-way ANOVA was
used to compare the density of corneal nerve fibers and post hoc
Tukey tests then were performed. (**P , 0.01). The data are
presented as mean6SEM. (B–F) Representative images of epithelial
layer on cornea whole mounts (232 mm2) with free nerve endings
labeled with anti-beta III tubulin (green). Scale bar: 500 lm.
Figure 3. Examination of corneal nerves in the subbasal layer
following corneal surface injury. (A) Density of mouse corneal
nerve fibers in the subbasal layer at baseline, and 2, 10, 21, and 42
days after CSI (n ¼ 3 for each time point). One-way ANOVA was
used to compare the density of corneal nerve fibers and post hoc
Tukey tests then were performed (**P , 0.01). The data are
presented as mean6SEM. (B–F) Representative images of subbasal
layer of cornea whole mounts (2 3 2 mm2) with nerve plexus
labeled with anti-beta III tubulin (green). Scale bar: 500 lm.
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CSI Induces Peripheral LS
We were intrigued that despite numerous mal-
adaptive changes in the corneal nerve architecture
after corneal injury (i.e., increased tortuosity, bead-
ing, and loss of subbasal nerve density shown in Figs.
2–5), pain behavior subsided within 14 days of injury
and did not spontaneously reinstate for up to 6 weeks
after injury (Fig. 1B). We hypothesized that endog-
enous opioid receptor signaling contributes to this
remission of nociceptive behavior, as described in
models of LS.17,24 To test this hypothesis, we
administered the global opioid antagonist/inverse
agonist, NTX, at 7 weeks after CSI when the pain
behavior resolved. As illustrated in Figure 6A,
naltrexone reinstated peak eye-wipe behavior in the
CSI group, but not in the sham group (P , 0.05).
Although LS is well established in the spinal cord and
brain, we asked the question whether, in our model,
NTX-induced reinstatement was paralleled by periph-
eral sensitization at the TG.17,25 We showed that
systemic NTX administration caused increased im-
munoreactivity to pERK, a marker of neuronal
activation, within NeuN-positive cells (neurons) at
the ophthalmic division of the TG in CSI mice
compared to sham mice (Figs. 6B, 6C, Supplementary
Fig. S3) or naive animals (Supplementary Fig. S4).
To further test whether LS could be partly
mediated by the peripheral LS, we studied the effect
of NLX-me, an opioid antagonist that does not cross
the blood–brain barrier. One drop of NLX-me (100
lM) applied to the ocular surface at 16 weeks after
CSI reinstated the ocular pain behavior in the CSI
mice, but had no effect in uninjured mice (Fig. 7).
These results suggest that peripheral endogenous
opioid receptor activation masks a sustained but
silent ocular hyperalgesia induced by CSI.
Discussion
Alkali burn to the ocular surface has been widely
used to study corneal neovascularization, wound
healing, and inflammation.18,26–28 Tissue injury and
remodeling beyond the ocular surface including
retinal and optic nerve gliosis also have been reported
after alkali injury to the cornea.26,28–31 Although
alkali burn causes corneal nerve damage and signif-
icant pain in patients, little is known about the long-
term effects of alkali burn injury to the oculo-
trigeminal sensory system.32 In this study, we
repurposed this injury model to study ocular sensi-
tivity by combining CSI with application of NaCl to
the cornea. The application of hypertonic saline to the
ocular surface elicited an eye-wiping response that
reflects an ongoing stimulation of nociceptors in the
cornea.23,33 Beyond studying short-term changes in
corneal nerves and ocular sensitivity, we determined
the long-term effects of CSI by establishing how LS
develops after ocular injury.
Figure 4. Assessment of the corneal stromal nerves following
corneal surface injury. (A) Density of mouse corneal nerve fibers in
the stromal layer at baseline, and 2, 10, 21, and 42 days after CSI (n
¼ 3 for each time point). One-way ANOVA was used to compare
the density of corneal nerve fibers and post hoc Tukey tests then
were performed (**P , 0.01). The data are presented as
mean6SEM. (B-F) Representative images of nerve trunks in
central 2 3 2 mm2 area of the stromal layer on corneal whole
mounts stained with anti-beta -III tubulin (green). Scale bar: 500
lm.
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Figure 5. Corneal nerves abnormalities following corneal surface injury. (A, B) Full-thickness confocal images of mouse whole cornea
stained with anti-b III tubulin antibody (green) at baseline (A) and 42 days after CSI-(B). Red circle denotes the area of corneal injury.
White boxes represent corneal nerves in the central (I and III) and peripheral (II and IV) cornea. Scale bar: 250 lm. (Ia-IVd) Layers of
corneal nerves are arranged by the following rows: (a) epithelial; (b) subbasal; (c) stromal; (d) 3D reconstruction. Neuromas (arrowhead)
and beading (arrow) are shown. 3D reconstruction images of corneal nerves shown in XY, XZ, and YZ planes with color coded z-depth.
!
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CSI Causes a Lasting Disruption of Corneal
Innervation
We found that CSI first led to corneal nerve
damage that peaked at 2 days, followed by a gradual
recovery (regeneration) over the next 6 weeks. Also,
CSI increased tortuosity, beading, and branching of
corneal nerves. These changes resemble those ob-
served in humans after corneal injury associated with
transplant, refractive surgery, or corneal abrasion,
and patients with ocular neuropathic pain exhibit
similar phenotypes as assessed by in vivo confocal
microscopy.34,35 Moreover, treatment with autolo-
gous serum tears resulted in normalization of corneal
nerve morphology and decreased photoallodynia.36 It
was interesting that in our model the subbasal layer
density remained decreased despite the quantitative
recovery to baseline of nerve density in the other
layers. This is consistent with other models of ocular
surface injury (dry eye, vitamin D deficiency, post-
refractive surgery, diabetic keratopathy) and it is
thought to be related to a disruption in Bowman’s
layer, which serves as a scaffold for the subbasal
plexus.37–39 Three-dimensional reconstitution of cor-
neal confocal images revealed that some of the
epithelial terminals arise directly from the stromal
nerves bypassing the subbasal area. Although we
showed that weeks after CSI the density of nerves
return to preinjury levels in the epithelial and stromal
layers, the distribution of these new nerves was
abnormal with large areas that remained deinner-
vated, neuroma formation and increased in length
and beading. The current study describes a novel
approach to model the pathologic changes associated
with ocular injury in humans. We concluded that CSI
produces a clinically-relevant and lasting disruption
of terminal architecture following reinnervation. This
defines a quantitative and morphologic assay to study
neuropathy in this corneal surface injury model.
CSI Induces Corneal Hypersensitivity
CSI increased sensitivity to local application of
hypertonic saline. This is consistent with previous
models of corneal injury-induced eye pain. For
example, either ultraviolet (UV) irradiation or chronic
application of benzalkonium chloride (BAC) produc-
es pain-like behavior, including hypertonic saline-
evoked eye-wiping.40–42 In our model, the hyperalge-
sia resolved 14 days after CSI. This is substantially
longer than previous reports describing enhanced eye-
wiping behavior that lasted just 3 to 7 days following
application of BAC and UV irradiation of the
cornea.40,41,42 This could be related to that fact that
alkali-induced CSI damages nerves in all layers of the
cornea, representing a much more extensive injury
compared to the BAC and UV models, both of which
affect the more superficial layers of the cornea.
Possible Mechanisms of the Initial CSI-
Induced Corneal Hypersensitivity
Our CSI model caused hyperalgesia starting as
early as 2 days after injury. This heightened nocicep-
tive response occurred despite the absence of nerve
terminals at the central cornea (Fig. 2C). This
suggested that adjacent uninjured nociceptors in the
peripheral cornea may contribute to secondary
hyperalgesia, which is thought to be mediated by
peripheral and central sensitization. Indeed, UV
irradiation sensitizes corneal nociceptors, and chronic
application of BAC and alkali burn to the ocular
surface all have been shown to cause sensitization
involving the TG and brainstem trigeminal nucle-
us.32,40–42
CSI Induces Chronic Ocular Neuropathic Pain
CSI produces an early hypersensitivity to hyper-
tonic saline that resolves within 14 days and remains
at baseline up to 6 weeks post-injury. This contrasts
with a much longer-lasting pathology of corneal
deinnervation and reinnervation. We proposed sever-
al explanations for this relationship: (1) anatomical
changes are unrelated to ocular pain, (2) the aberrant
regeneration of corneal nerves might mediate the
resolution of pain behavior by an unidentified
mechanism, and (3) a long-lasting sensitization of
corneal nociceptive transmission develops that is
masked by an upregulation of pain inhibitory
mechanisms unrelated to corneal reinnervation ab-
normalities. The latter is supported by our observa-
tion that systemic administration of naltrexone 10
weeks after injury causes reinstatement of the corneal
hypersensitivity and an associated increase in pERK
activity in the TG neurons.
 
Scale bar: 50 lm. (C) Average length of corneal nerve fibers in epithelial, subbasal, and stromal layers at baseline (n¼ 3) and 42 days
after CSI (n ¼ 3). Student’s t-tests were used to compare the length of corneal nerve fibers between sham and injury groups (**P ,
0.01). Data are presented as mean6SEM.
9 TVST j 2019 j Vol. 8 j No. 2 j Article 6
Cho et al.
Downloaded from tvst.arvojournals.org on 08/15/2019
Figure 6. NTX unmasks corneal surface injury-induced neuronal sensitization. (A) 2M NaCl-induced eye-wiping behavior in sham (n¼ 7)
and CSI (0.75N NaOH; n¼ 5) groups at baseline, 10 days, and 7 weeks after CSI before and after subcutaneous administration of NTX (3
mg/kg). Linear mixed models were used to compare the groups over time (*P , 0.05). (B) Representative images of ophthalmic division
(V1) of the TG at 7 weeks after CSI without NTX (left columns) and with NTX (right columns; n¼ 3/group): (Top) pERK-positive cells in red,
!
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Extracellular signal-regulated kinase (ERK), a
mitogen-activated protein kinase (MAPK), is phos-
phorylated in neurons by noxious stimulation or tissue
injury.43 ERK phosphorylation is essential for the
development of neuronal sensitization that contributes
to hypersensitivity.44 Multiple trigeminal nerve dam-
age-associated chronic pain models have reported
pERK-expressing neurons in the trigeminal system.
For example, increased pERK expression was observed
in V2 and V3 branches of the TG after injection of
calcitonin gene-related peptide (CGRP) or CFA into
the TMJ capsule as well as after partial infraorbital
nerve ligation (pIONL).45–48 In addition, a recent study
showed that corneal alkali burn injury induced
spontaneous ocular pain and increased pERK expres-
sion in the trigeminal nucleus at the central nervous
system, including the subnucleus caudalis/upper cervi-
cal cord (Vc/V1), anterior cingulated cortex (ACC),
insular cortex, and rostroventral medulla.32 Together
these data indicate that chronic ocular pain is masked
by opioid receptor mediated latent sensitization.
Furthermore, our data showing that NLX-me, a
peripheral opioid receptor antagonist, also reinstates
ocular pain supported the hypothesis that recovery
from ocular pain happens after the establishment of
peripheral LS in this model. This raises the intriguing
possibility that peripheral LS contributes to chronic
ocular pain. We speculated that failure to develop or
maintain compensatory opioid receptor activation
could explain the varied susceptibility to ocular pain
development after eye surgery or injury. As previously
discussed, chronic ocular pain periodically cycles or
‘‘flares-up’’ from time to time. This silenced sensiti-
zation seen in murine models mimics the apparent
fluctuations in pain after injury. LS, then, might
explain the remitting nature of chronic ocular pain
that ensues after eye trauma. Our finding that
systemic and topical opioid antagonists reinstate
ocular pain in injured mice, but not in sham-treated
mice, unveils a new potential diagnostic and thera-
peutic opportunity to distinguish chronic ocular pain
from dry eye and acute ocular pain. Beyond episodic
pain, the failure of endogenous opioid receptor
signaling could be a neuropathologic basis of
persistent post-injury eye pain.
Figure 7. Corneal surface injury mediates peripheral latent sensitization that masks chronic ocular pain. Eye-wiping behavior of sham (n
¼6) and CSI (n¼8) mice at baseline and 10 days, 28 days, and 10 and 16 weeks after CSI with 2 M NaCl stimulus. On week 10, NTX (3 mg/
kg) was subcutaneously administered before eye-wiping test, and at 16 weeks NLX-me (100 lM) was topically applied to the ocular
surface before ocular stimulation with hypertonic saline. Linear mixed models were used to compare the groups over time (between
sham and CSI, #P, 0.05, ##P,0.01, within CSI, *,0.05, **P, 0.01). The data are presented as mean6SEM.
 
(Middle) NeuN-positive cells in green, (Bottom) colocalization of pERK and NeuN cells in yellow (arrow). Scale bar: 50 lm. (C) Percentage of
pERK-positive neurons (B; yellow) in sham and CSI groups (n¼ 3/group). Student’s t-tests were used to compare %pERK-positive neurons
between groups (*P , 0.05). The data are presented as mean6SEM.
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Summary and Conclusions
In summary, we present a model of ocular
neuropathic pain that exhibits LS. Our data are
consistent with a growing body of literature showing
that chronic ocular pain is more complex than mere
ocular surface dryness and suggests that long-lasting
neurosensory changes are critical for the develop-
ment of chronic ocular pain.7,35,49–52 We concluded
that our experimental model of chronic eye pain
may be useful in elucidating underlying pathophys-
iology, developing novel diagnostic methods, and
discovering new therapeutic targets for chronic eye
pain.
Our work revealed a new diagnostic and thera-
peutic target to prevent the transition from nerve
injury-induced acute pain to chronic pain and to
alleviate enhanced sensitivity in the chronic pain state.
Future studies should focus on determining methods
to circumvent LS and to enhance the activity of mu-
opioid receptors in the oculo-trigeminal system.
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